Leong Justin 4/A
4/A · RESMED INC · Filed Nov 18, 2021
Insider Transaction Report
Form 4/AAmended
RESMED INCRMD
Leong Justin
Chief Product Officer
Transactions
- Tax Payment
ReMed Common Stock
2021-11-16$254.81/sh−765$194,930→ 49,092 total - Award
ReMed Common Stock
2021-11-18+638→ 49,730 total - Award
ReMed Common Stock
2021-11-16$254.81/sh+9,162$2,334,569→ 49,857 total
Footnotes (3)
- [F1]Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met.
- [F2]Amended to report the disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018, 11/21/2019 and 11/19/2020.
- [F3]Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.